Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CERTITEM renal transplant fibrosis study
2009-011473-33Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2009
- Modality
- Small Molecules, Peptides, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of everolimus, cyclosporine, mycophenolate sodium and basiliximab in kidney transplant (2 arms), sponsored by Novartis. Started May 2009; status: completed.
02
Drugs
everolimuscyclosporinemycophenolate sodiumbasiliximab
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2009-011473-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011473-33.